Copyright
©The Author(s) 2020.
World J Gastroenterol. Oct 14, 2020; 26(38): 5849-5862
Published online Oct 14, 2020. doi: 10.3748/wjg.v26.i38.5849
Published online Oct 14, 2020. doi: 10.3748/wjg.v26.i38.5849
Table 2 Comparison between the number of platelets measurements and co-morbidities between cases with cirrhosis and controls, n (%)
Cirrhosis | Control | OR | 95%CI | ||
Low | Up | ||||
Platelets measurements | 15.59 (14.36) | 10.69 (10.33) | 1.033 | 1.031 | 1.036 |
Platelets measurements: 3-10 | 2510 (47.74) | 10482 (66.45) | 1 | ||
11-20 | 1409 (26.8) | 3395 (21.52) | 1.73 | 1.61 | 1.87 |
21+ | 1339 (25.47) | 1897 (12.03) | 2.95 | 2.72 | 3.20 |
Diabetes | 326 (6.2) | 847 (5.37) | 1.17 | 1.02 | 1.33 |
HTN | 170 (3.23) | 447 (2.83) | 1.15 | 0.96 | 1.37 |
CKD | 390 (7.42) | 961 (6.01) | 1.24 | 1.09 | 1.4 |
Dyslipidemia | 915 (17.4) | 2843 (18.02) | 0.96 | 0.88 | 1.04 |
Smoking | 1563 (29.73) | 3470 (22) | 1.5 | 1.398 | 1.609 |
- Citation: Gotlieb N, Schwartz N, Zelber-Sagi S, Chodick G, Shalev V, Shibolet O. Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis. World J Gastroenterol 2020; 26(38): 5849-5862
- URL: https://www.wjgnet.com/1007-9327/full/v26/i38/5849.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i38.5849